Prognosis of Adjuvant SOX vs XELOX Chemotherapy for Gastric Cancer After D2 Gastrectomy in Chinese Patients

INTRODUCTION: To compare the prognosis of adjuvant SOX (S-1 and oxaliplatin) vs XELOX (capecitabine and oxaliplatin) chemotherapy in Chinese patients with gastric cancer (GC) after D2 gastrectomy. METHODS: This was a real-world study of patients with GC (stages II–III) who underwent D2 gastrectomy a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shan, Wang, Yan, Cheng, Xi, Lv, Minzhi, Cui, Yuehong, Li, Wei, Yu, Yiyi, Li, Qian, Liu, Tianshu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568598/
https://www.ncbi.nlm.nih.gov/pubmed/33116865
http://dx.doi.org/10.2147/CMAR.S270387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568598/
https://www.ncbi.nlm.nih.gov/pubmed/33116865
http://dx.doi.org/10.2147/CMAR.S270387

Ejemplares similares